Increased risk of myelotoxicity in elderly patients with non‐Hodgkin lymphoma

This publication has 27 references indexed in Scilit:

• AGING AND CANCER IN AMERICA: Demographic and Epidemiologic Perspectives
  Published by Elsevier ,2005
• CHOP Chemotherapy plus Rituximab Compared with CHOP Alone in Elderly Patients with Diffuse Large-B-Cell Lymphoma
  New England Journal of Medicine, 2002
• Dose and Dose Intensity as Determinants of Outcome in the Adjuvant Treatment of Breast Cancer
  JNCI Journal of the National Cancer Institute, 1998
• Comparison of doxorubicin and mitoxantrone in the treatment of elderly patients with advanced diffuse non-Hodgkin's lymphoma using CHOP versus CNOP chemotherapy.
  Journal of Clinical Oncology, 1995
• Adjuvant Cyclophosphamide, Methotrexate, and Fluorouracil in Node-Positive Breast Cancer — The Results of 20 Years of Follow-up
  New England Journal of Medicine, 1995
• P-VEBEC: A new 8-weekly schedule with or without rG-CSF for elderly patients with aggressive non-Hodgkin's lymphoma (NHL)
  Annals of Oncology, 1994
• Cost-benefit of granulocyte colony-stimulating factor administration in older patients with non-Hodgkin's lymphoma treated with combination chemotherapy
  Annals of Oncology, 1994
• Prognostic significance of received relative dose intensity in non-Hodgkin's lymphoma patients: Application to LNH-87 protocol
  Annals of Oncology, 1993
• Survival of diffuse large cell lymphoma. A multivariate analysis including dose intensity variables
  Cancer, 1990
• Prognostic significance of actual dose intensity in diffuse large-cell lymphoma: results of a tree-structured survival analysis.
  Journal of Clinical Oncology, 1990